TETmedical, Inc. (Tethered Enzyme Technologies) is a clinical stage platform nanomedicine company focused on in vitro diagnostics that enable insights for high-consequence disease decision making. TET emerged out of groundbreaking innovations originating at Cornell University. Our device measures less than a hundredth the width of a human hair. It is a miniature, functioning, highly stable molecular machine, capable of performing chemical operations with high sensitivity, stability, and speed (thousands of times faster than antibody assays): a patented “TET nanobot”, consisting of thousands of enzymes tethered to a silica nanoparticle. TETmedical’s first product is the NSE-FAST (Neuron Specific Enolase Functional Activity Stroke Test), the first in-vitro diagnostic for brain injury from stroke.

TETmedical, Inc.

The Ithaca office focuses on innovation in biomedical research and engineering, fostering advancements in healthcare technology.

TETmedical, Inc.

Org chart

Teams

Offices

TETmedical, Inc.

Org chart

Teams

Offices

Related companies